Back
Allogene Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
59
ALLO
Allogene Therapeutics
Last Price:
3.19
Seasonality Move:
-10.11%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLO is experiencing slight buying pressure.
Allogene Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.73 | Buy |
| 20-day SMA: | 2.72 | Buy |
| 50-day SMA: | 2.71 | Buy |
| 200-day SMA: | 3.18 | Sell |
| 8-day EMA: | 2.8 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 2.71 | Buy |
| 200-day EMA: | 3.09 | Sell |
Allogene Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 58.5 | Buy |
| Chaikin Money Flow: | 974664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 2.83) | Buy |
| Bollinger Bands (100): | (2.39 - 2.91) | Buy |
Allogene Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.99 while ALLO 8-day simple moving average is 2.73, which is a Buy signal.
- The stock price of ALLO is 2.99 while Allogene Therapeutics 20-day SMA is 2.72, which makes it a Buy.
- Allogene Therapeutics 50-day simple moving average is 2.71 while ALLO share price is 2.99, making it a Buy technically.
- ALLO stock price is 2.99 and Allogene Therapeutics 200-day simple moving average is 3.18, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Buy
59
Allogene Therapeutics (ALLO)
is a Buy
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a Buy
The current Allogene Therapeutics [ALLO] share price is $2.99. The Score for ALLO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
625.24M
Price in USD:
2.99
Share Volume:
2.6M
Allogene Therapeutics 52-Week Range
52-Week High:
5.78
52-Week Low:
2.01
Buy
59
Allogene Therapeutics (ALLO)
is a Buy
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?
The Allogene Therapeutics stock price is 2.99 USD today. -
Will ALLO stock go up or go down?
Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Allogene Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is not overvalued.
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.99 while ALLO 8-day exponential moving average is 2.80, which is a Buy signal.
- The stock price of ALLO is 2.99 while Allogene Therapeutics 20-day EMA is 2.74, which makes it a Buy.
- Allogene Therapeutics 50-day exponential moving average is 2.71 while ALLO share price is 2.99, making it a Buy technically.
- ALLO stock price is 2.99 and Allogene Therapeutics 200-day simple moving average is 3.09, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
- ALLO Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Allogene Therapeutics is a Buy
- Allogene Therapeutics Relative Strength Index (RSI) is 58.5, which suggest Allogene Therapeutics is overbought
- The Bollinger Bands (25) for Allogene Therapeutics is (2.57 - 2.83), which suggest Allogene Therapeutics is a Buy
- The Bollinger Bands (100) for Allogene Therapeutics is (2.39 - 2.91), which suggest Allogene Therapeutics is a Buy
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.